# Decheng Capital Global Life Sciences Fund V-B, L.P. — Form D/A

Decheng Capital Global Life Sciences Fund V-B, L.P. of GRAND CAYMAN, E9, a pooled investment fund, filed a Form D amendment with the SEC on 2025-10-03. The offering totals $700.0M, of which $452.0M was reported sold. Industry: Pooled Investment Fund.

## Offering

- Filed: 2025-10-03
- Form: D/A
- Accession: 0001231919-25-000281
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Total offering: $700.0M
- Amount sold: $452.0M
- Remaining: $248.0M
- Investors: 42
- Date of first sale: 2024-06-18
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-516125

## Issuer

- Name: Decheng Capital Global Life Sciences Fund V-B, L.P.
- CIK: 0002026146
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2024
- Address: C/O MAPLES CORPORATE SERVICES LIMITED, GRAND CAYMAN, E9, KY1-1104
- Phone: 345-949-8066

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Xiangmin Cui | Director | Houston, TX |
| Yuheng Qiu | Director | Grand Cayman, E9 |
| N/A NA Decheng Capital Management V (Cayman), LLC | Promoter | Grand Cayman, E9 |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-06-17](https://search.stillhousedata.com/formd/0002015545-24-000002) | D | $700.0M | — |

## More

- [CIK 2026146 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2026146&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001231919-25-000281.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.